Avingtrans AGM Part 227 Nov 2024 12:28
Whilst the equipment is aimed at the Orthopaedic market there has been no sales approach to hospitals for the simple reason it would be a hard sell against the established MRI manufacturers of GE & Siemens etc.
As to the future of Magnetica and Adaptix the present uses are dictated by the bandwidth currently used in the equipment but research is being undertaken as to what else might the equipment be capable of if experiments are tried into varying bandwidths. At the moment both products are still much below the radar and their true value cannot be seen until more of the products become available within the fields of NDT, Veterinary & Orthopaedic. The spectre of Trade tariffs being imposed by the impending Trump administration is not of undue concern as much of the equipment could be manufactured in the USA and whilst the spectrometer is manufactured by Tecmag in the USA there will of course be a tariff on the Magnets produced at Abingdon. A possible IPO of the division or part thereof might be considered be it on the FTSE market or NASDAQ that remains to be seen or perhaps a trade sale to an interested buyer.
Turning to the rest of the Group, the Nuclear waste boxes for Sellafield are ongoing, manufacturing about 10 boxes per month as part of the current contract, there is no expected customers envisaged from outside the UK as these boxes are to a very high spec compared to other countries, this is because of the nature of the waste, especially from the former Magnox sites that were not deployed anywhere else in the world.
The usual mirage of the Sellafield tender appearing for around £800m is reckoned to be once again “next year” as has been said on an annual basis since 2018, whilst the initial competitor has withdrawn from the field, likely participants in the competition are thought to be Bendalls, Graham Engineering and possibly Goodwin. In each case it is more than likely that there will need to be a technology transfer which would of course bring further remuneration to Avingtrans. Should they be approached by one of the larger engineering companies looking at a joint venture to manufacture the boxes such approach will be declined.
Booths are well into the HS2 door contract and will soon commence manufacture of doors for the stations, the cancellation of the Northern part of the project is not seen as too much of a loss given they are busy with other work on such sites as the Elizabethan Line for London Underground, the Board believe there is still much good value to come within Booths and do not anticipate a sale in the short term.
Whilst there may be small bolt on acquisitions to the existing units, no sizeable additions are expected perhaps until one of the existing divisions is sold.
In conclusion it was once again a most interesting meeting indicating there is a lot going on in each of the many divisions and as in the past I was happy to propose a vote of thanks to the Board.